The Prostate Centre at VGH received $20 million donation by Vancouver businessman Jim Pattison
In 1999, the Vancouver Prostate Centre received a $20 million donation by Vancouver businessman Jim Pattison, the largest…
-
-
Michael Smith Genome Science Centre was founded
In 1999, Michael Smith, recipient of the 1993 Nobel Prize in Chemistry, founded Canada’s Michael Smith Genome Science…
-
The Indiana University Cancer Center became an NCI-designated cancer center
In 1999, The Indiana University (IU) Cancer Center became an National Cancer Institute (NCI)-designated cancer center. Its mission…
-
The Hudson-Webber Cancer Research Center opened
In 1999, the Hudson-Webber Cancer Research Center opened to serve as a ‘translational’ research facility, bridging the gaps…
-
Timothy J Eberlein, MD was named director of the Alvin J Siteman Cancer Center
In 1999, Timothy J. Eberlein, MD was named director of the Alvin J. Siteman Cancer Center. As director…
-
Washington University – St Louis radiation oncologists helped develop the world’s first big bore CT scanner
In 1999, Washington University – St. Louis radiation oncologists were instrumental in developing the world’s first big bore…
-
Biotechnology | NIH | Oncology | Therapeutics
The Eppley Cancer Center became a National Cancer Institute designated cancer center
In 1999, the Eppley Cancer Center became a National Cancer Institute (NCI) designated cancer center. NCI grant funding…
-
Mouse model of prostate cancer was developed at Washington University – St Louis
On Dec. 22, 1998, Washington University – St. Louis researcher Jeffrey I. Gordon, MD and colleagues developed a…
-
Medical College of Georgia researchers identified enzyme role in preventing a mother’s immune system from rejecting a fetus
On Sept. 8, 1998, the Medical College of Georgia researchers Dr. David Munn and immunologist Andrew Melllor identified…
-
The Seattle Cancer Care Alliance was formed
On Jun. 16, 1998, University of Washington Medicine, Fred Hutchinson Cancer Research Center and Seattle Children’s announced the…
-
Biotechnology | FDA | Oncology | Therapeutics
The FDA approved Genentech drug Xeloda (capecitabine)
On April 30, 1998, the U.S. Food and Drug Administration (FDA) approved the Genentech’s drug Xeloda (capecitabine) for…
-
Biotechnology | Diagnostics | NIH | Oncology | Therapeutics
The City of Hope Cancer Center received NCI comprehensive cancer center designation
In 1998, National Cancer Institute (NCI) awarded the City of Hope Cancer Center NCI-comprehensive cancer center designation. City…
-
The Norris Comprehensive Cancer Center received a $5 million gift from local philanthropist Henrietta Lee
In 1998, The Norris Comprehensive Cancer Center received a $5 million gift from local philanthropist Henrietta Lee which…
-
Dr. Patrick Lee developed a reovirus that can infect and kill cancer cells without harming healthy cells
In 1998, University of Calgary’s Dr. Patrick Lee revealed that reovirus injected in mice shrank tumours from brain…
-
Biotechnology | Diagnostics | NIH | Oncology | Therapeutics
Cancer incidence rates showed first sustained decline since NCI began keeping records in 1973
In 1998, Cancer incidence rates showed first sustained decline since the National Cancer Institute (NCI) began keeping records…
-
Yale Cancer Center researchers discovered the gene, Survivin, which is linked to the detection of some cancers
In 1998, Yale Cancer Center researchers discovered the gene, Survivin, which is linked to the detection of some…
-
Tamoxifen, created with the MCF-7 breast cancer cell line established by Karmanos, reduced the incidence of some breast cancer outcomes
In 1998, Tamoxifen, created with the MCF-7 breast cancer cell line established by Karmanos, was revealed to reduce…
-
Biotechnology | Diagnostics | NIH | Oncology | Therapeutics
The Case Cancer Center was recognized as an NCI-designated comprehensive cancer center
In 1998, The Case Cancer Center (Case CCC) was recognized as an National Cancer Institute (NCI)-designated comprehensive cancer…
-
The prevalence of U.S. adult smoking declined to 24.1 percent in 1998
In 1998, the Centers for Disease Control and Prevention (CDC) reported that an estimated 47.2 million adults (24.1%),…
-
The National Cancer Institute Director’s Consumer Liaison Group was established
On Nov. 6, 1997, the National Cancer Institute Director’s Consumer Liaison Group was established to advise and provide…
-
The UCI Chao Family Comprehensive Cancer Center gained comprehensive cancer center status
In 1997, the the University of California, Irvine (UCI) Chao Family Comprehensive Cancer Center (CFCCC) gained NCI designated…
-
Biotechnology | Diagnostics | NIH | Oncology | Therapeutics
The University of Colorado Cancer Center received comprehensive cancer center designation from NCI
In 1997, the University of Colorado Cancer Center (CU) at the Anschutz Medical Campus received National Cancer Institute…
-
The Robert H. Lurie Comprehensive Cancer Center of Northwestern University received its NCI ‘comprehensive’ designation
In 1997, the Robert H. Lurie Comprehensive Cancer Center of Northwestern University received its National Cance Institute ‘comprehensive’…
-
Biotechnology | Diagnostics | NIH | Oncology | Therapeutics
The Oregon Cancer Center was established with a grant from the National Cancer Institute
In 1997, the Oregon Cancer Center was established with a grant from the National Cancer Institute (NCI) of…
-
OHSU achieved National Cancer Institute designation, the first and only cancer research and care center in Oregon
In 1997, Oregon Health & Science University (OHSU) announced that the institute achieved National Cancer Institute (NCI) designation,…
-
The Huntsman Cancer Institute received National Comprehensive Cancer Network designation
In 1997, the Huntsman Cancer Institute received National Comprehensive Cancer Network (NCCN) designation. In 1995, the Center earned…
-
The Cancer Genome Anatomy Project was launched
In 1997, the Cancer Genome Anatomy Project (CGAP), created by the National Cancer Institute (NCI), is a multi-year…
-
SeaMed Corp was founded
On Oct. 2, 1996, SeaMED Corp. was founded in Redmond by Bob Berg. The company manufactured cell-production systems,…
-
Topotecan (Hycamptin) was approved by the FDA for the treatment of metastatic ovarian cancer
On Jul. 1, 1996, topotecan (Hycamptin), the first of a class of drugs that interferes with the enzyme…
-
The USC Norris Comprehensive Cancer Center and Hospital opened expanded facilities
On Mar. 26, 1996, the USC Norris Comprehensive Cancer Center and Hospital opened their expanded facilities that included…
